WallStSmart

Archrock Inc (AROC)vsNOV Inc. (NOV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

NOV Inc. generates 487% more annual revenue ($8.74B vs $1.49B). AROC leads profitability with a 21.6% profit margin vs 1.7%. NOV appears more attractively valued with a PEG of 1.19. AROC earns a higher WallStSmart Score of 74/100 (B).

AROC

Strong Buy

74

out of 100

Grade: B

Growth: 9.3Profit: 8.5Value: 10.0Quality: 4.3
Piotroski: 2/9Altman Z: 0.34

NOV

Buy

50

out of 100

Grade: C-

Growth: 3.3Profit: 5.0Value: 4.7Quality: 7.0
Piotroski: 3/9Altman Z: 1.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AROCUndervalued (+62.2%)

Margin of Safety

+62.2%

Fair Value

$85.64

Current Price

$36.86

$48.78 discount

UndervaluedFair: $85.64Overvalued
NOVSignificantly Overvalued (-634.7%)

Margin of Safety

-634.7%

Fair Value

$2.65

Current Price

$19.62

$16.97 premium

UndervaluedFair: $2.65Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AROC5 strengths · Avg: 9.2/10
Operating MarginProfitability
43.2%10/10

Strong operational efficiency at 43.2%

EPS GrowthGrowth
95.4%10/10

Earnings expanding 95.4% YoY

Return on EquityProfitability
22.9%9/10

Every $100 of equity generates 23 in profit

Profit MarginProfitability
21.6%9/10

Keeps 22 of every $100 in revenue as profit

Revenue GrowthGrowth
15.5%8/10

15.5% revenue growth

NOV1 strengths · Avg: 10.0/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

Areas to Watch

AROC3 concerns · Avg: 3.0/10
PEG RatioValuation
1.634/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Altman Z-ScoreHealth
0.342/10

Distress zone — elevated risk

NOV4 concerns · Avg: 3.3/10
Altman Z-ScoreHealth
1.954/10

Grey zone — moderate risk

Return on EquityProfitability
2.4%3/10

ROE of 2.4% — below average capital efficiency

Profit MarginProfitability
1.7%3/10

1.7% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : AROC

The strongest argument for AROC centers on Operating Margin, EPS Growth, Return on Equity. Profitability is solid with margins at 21.6% and operating margin at 43.2%. Revenue growth of 15.5% demonstrates continued momentum.

Bull Case : NOV

The strongest argument for NOV centers on Price/Book. PEG of 1.19 suggests the stock is reasonably priced for its growth.

Bear Case : AROC

The primary concerns for AROC are PEG Ratio, Piotroski F-Score, Altman Z-Score.

Bear Case : NOV

The primary concerns for NOV are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 50.0x leaves little room for execution misses. Thin 1.7% margins leave little buffer for downturns.

Key Dynamics to Monitor

AROC profiles as a growth stock while NOV is a value play — different risk/reward profiles.

NOV carries more volatility with a beta of 0.93 — expect wider price swings.

AROC is growing revenue faster at 15.5% — sustainability is the question.

NOV generates stronger free cash flow (472M), providing more financial flexibility.

Bottom Line

AROC scores higher overall (74/100 vs 50/100), backed by strong 21.6% margins and 15.5% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Archrock Inc

ENERGY · OIL & GAS EQUIPMENT & SERVICES · USA

Archrock, Inc. is an energy infrastructure company in the United States. The company is headquartered in Houston, Texas.

Visit Website →

NOV Inc.

ENERGY · OIL & GAS EQUIPMENT & SERVICES · USA

NOV Inc. is an American multinational corporation based in Houston, Texas. It is a leading worldwide provider of equipment and components used in oil and gas drilling and production operations, oilfield services, and supply chain integration services to the upstream oil and gas industry.

Visit Website →

Want to dig deeper into these stocks?